Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte Function.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 09 08 2021
accepted: 20 10 2021
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 8 2 2022
Statut: epublish

Résumé

T-lymphocytes (T cells) play a major role in adaptive immunity and current immune checkpoint inhibitor-based cancer treatments. The regulation of their function is complex, and in addition to cytokines, receptors and transcription factors, several non-coding RNAs (ncRNAs) have been shown to affect differentiation and function of T cells. Among these non-coding RNAs, certain small microRNAs (miRNAs) including miR-15a/16-1, miR-125b-5p, miR-99a-5p, miR-128-3p, let-7 family, miR-210, miR-182-5p, miR-181, miR-155 and miR-10a have been well recognized. Meanwhile, IFNG-AS1, lnc-ITSN1-2, lncRNA-CD160, NEAT1, MEG3, GAS5, NKILA, lnc-EGFR and PVT1 are among long non-coding RNAs (lncRNAs) that efficiently influence the function of T cells. Recent studies have underscored the effects of a number of circular RNAs, namely circ_0001806, hsa_circ_0045272, hsa_circ_0012919, hsa_circ_0005519 and circHIPK3 in the modulation of T-cell apoptosis, differentiation and secretion of cytokines. This review summarizes the latest news and regulatory roles of these ncRNAs on the function of T cells, with widespread implications on the pathophysiology of autoimmune disorders and cancer.

Identifiants

pubmed: 34804042
doi: 10.3389/fimmu.2021.756042
pmc: PMC8599985
doi:

Substances chimiques

RNA, Untranslated 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

756042

Informations de copyright

Copyright © 2021 Taheri, Barth, Kargl, Rezaei, Ghafouri-Fard and Pichler.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell Rep. 2019 Aug 20;28(8):2169-2181.e4
pubmed: 31433990
Cancer Biol Ther. 2019;20(5):653-665
pubmed: 30582709
Atherosclerosis. 2019 Dec;291:78-86
pubmed: 31704554
Curr Genomics. 2010 Nov;11(7):537-61
pubmed: 21532838
J Cell Physiol. 2019 Jul;234(7):12029-12041
pubmed: 30548623
J Biol Chem. 2012 Jan 20;287(4):2608-17
pubmed: 22139839
J Immunol. 2018 Oct 1;201(7):2165-2175
pubmed: 30150287
Clin Exp Immunol. 2018 Feb;191(2):166-179
pubmed: 28987000
Int Rev Immunol. 2019;38(5):232-245
pubmed: 31411520
Immunol Cell Biol. 2021 Mar;99(3):323-332
pubmed: 32970351
RNA Biol. 2015;12(4):381-8
pubmed: 25746834
Exp Ther Med. 2018 Nov;16(5):4246-4252
pubmed: 30344699
Biochem Pharmacol. 2020 Apr;174:113822
pubmed: 31987855
Cell Signal. 2019 Jul;59:182-190
pubmed: 30593845
J Leukoc Biol. 2018 May;103(5):855-866
pubmed: 29656550
Cell. 2014 Aug 14;158(4):749-763
pubmed: 25126783
Clin Immunol. 2017 Oct;183:121-131
pubmed: 28822831
Mucosal Immunol. 2020 Mar;13(2):303-312
pubmed: 31628427
Nat Commun. 2019 Dec 13;10(1):5697
pubmed: 31836704
Chemistry. 2010 Jan 25;16(4):1186-92
pubmed: 20024999
J Immunol. 2018 Mar 1;200(5):1618-1626
pubmed: 29378913
Clin Exp Allergy. 2019 Aug;49(8):1116-1127
pubmed: 31148290
Biosci Rep. 2019 Sep 20;39(9):
pubmed: 31501353
Oncol Lett. 2020 Jul;20(1):235-247
pubmed: 32565950
Int J Mol Med. 2020 Aug;46(2):859-868
pubmed: 32467993
Life Sci. 2020 Oct 15;259:118218
pubmed: 32784057
Nat Immunol. 2013 Apr;14(4):404-12
pubmed: 23396170
Biomed Pharmacother. 2019 Mar;111:386-394
pubmed: 30594051
Biosci Rep. 2018 Jul 31;38(4):
pubmed: 29853534
Clin Cancer Res. 2017 Mar 1;23(5):1323-1333
pubmed: 27601590
Biochem Biophys Res Commun. 2020 Aug 27;529(3):784-792
pubmed: 32736708
Lupus. 2020 Jun;29(7):727-734
pubmed: 32321346
Cell Biosci. 2020 Feb 12;10:15
pubmed: 32082540
Cancers (Basel). 2019 Dec 12;11(12):
pubmed: 31842362
FASEB J. 2018 Nov;32(11):5967-5975
pubmed: 29792732
Hepatology. 2018 Mar;67(3):1027-1040
pubmed: 29023933
Int J Mol Sci. 2019 Feb 01;20(3):
pubmed: 30717168
Biomed Pharmacother. 2019 Mar;111:51-59
pubmed: 30576934
Nat Commun. 2017 May 25;8:15129
pubmed: 28541302
Cell Mol Immunol. 2019 Feb;16(2):112-125
pubmed: 29429995
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11916-11925
pubmed: 31138702
J Autoimmun. 2020 Feb;107:102358
pubmed: 31757716
Arch Biochem Biophys. 2020 Nov 30;695:108611
pubmed: 33002446
Aging (Albany NY). 2019 Jul 15;11(13):4463-4477
pubmed: 31326963
J Mol Med (Berl). 2020 Feb;98(2):309-320
pubmed: 32002568
Int Immunopharmacol. 2019 Oct;75:105778
pubmed: 31494340
Br J Cancer. 2015 Aug 11;113(4):569-73
pubmed: 26158421
Cell Death Dis. 2019 Jan 18;10(2):46
pubmed: 30718475
Cell Mol Neurobiol. 2021 May;41(4):619-649
pubmed: 32468442
Cell Physiol Biochem. 2018;49(2):828-836
pubmed: 30165351
Mol Cell Biochem. 2019 Apr;454(1-2):67-76
pubmed: 30382432
Front Immunol. 2020 May 28;11:852
pubmed: 32547537
Biochem J. 2012 Jan 1;441(1):1-21
pubmed: 22168436
Sci Immunol. 2018 May 4;3(23):
pubmed: 29728425
Cell Death Dis. 2020 Apr 2;11(4):216
pubmed: 32242002
FEBS J. 2017 Jul;284(13):1952-1966
pubmed: 28132417
Front Immunol. 2018 Oct 29;9:2512
pubmed: 30420860
Oncogene. 2015 Sep 24;34(39):5003-11
pubmed: 25619839
Onco Targets Ther. 2019 Nov 07;12:9407-9419
pubmed: 31819475
World J Pediatr. 2020 Feb;16(1):99-110
pubmed: 31102153
Cytokine. 2015 Jul;74(1):5-17
pubmed: 25458968
Mol Med Rep. 2019 Oct;20(4):3617-3624
pubmed: 31485649
Biochem Biophys Res Commun. 2018 Feb 5;496(2):352-358
pubmed: 29331376
J Cell Physiol. 2019 Dec;234(12):22477-22484
pubmed: 31119756
Mol Immunol. 2020 Sep;125:32-42
pubmed: 32629323
J Clin Invest. 2018 Jun 1;128(6):2551-2568
pubmed: 29757188
Front Immunol. 2018 Nov 27;9:2754
pubmed: 30538706
Pediatr Allergy Immunol. 2019 Jun;30(4):434-442
pubmed: 30734973
Clin Immunol. 2014 Jul;153(1):73-8
pubmed: 24704577
Transpl Immunol. 2020 Oct;62:101320
pubmed: 32687860
Immunology. 2018 Sep;155(1):137-149
pubmed: 29700819
Arch Oral Biol. 2019 Mar;99:126-133
pubmed: 30682715
Development. 2016 Sep 1;143(17):3050-60
pubmed: 27578176
FASEB J. 2017 Feb;31(2):519-525
pubmed: 27756768
Trends Cell Biol. 2012 Nov;22(11):557-66
pubmed: 22995730
Nat Rev Immunol. 2009 Feb;9(2):125-35
pubmed: 19151747
Biomed Pharmacother. 2019 Oct;118:109129
pubmed: 31326791
Front Immunol. 2019 Jun 13;10:1367
pubmed: 31275315
Int J Mol Sci. 2016 Apr 15;17(4):573
pubmed: 27092491
J Immunol. 2018 Jun 15;200(12):4170-4179
pubmed: 29720426
Clin Epigenetics. 2021 Jan 6;13(1):1
pubmed: 33407852
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Int Immunopharmacol. 2020 Nov;88:106992
pubmed: 33182021
J Autoimmun. 2019 Jan;96:94-103
pubmed: 30201436
Cancer Lett. 2015 Jun 28;362(1):45-60
pubmed: 25779676
Blood. 2018 Apr 26;131(17):1974-1986
pubmed: 29530952
Front Immunol. 2021 Mar 12;12:601298
pubmed: 33776993
Nature. 1998 Jan 22;391(6665):410-3
pubmed: 9450761
Nat Rev Immunol. 2003 Nov;3(11):900-11
pubmed: 14668806
Nat Immunol. 2014 Apr;15(4):393-401
pubmed: 24608041
Mol Immunol. 2021 Jun;134:202-209
pubmed: 33813201
Int Immunopharmacol. 2019 Oct;75:105761
pubmed: 31325726
Nat Immunol. 2018 Oct;19(10):1112-1125
pubmed: 30224822
Parasit Vectors. 2021 Jun 3;14(1):295
pubmed: 34082780
In Vitro Cell Dev Biol Anim. 2020 Jan;56(1):67-74
pubmed: 31768762
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Neuroimmunomodulation. 2019;26(1):7-18
pubmed: 30703767
Immunol Rev. 2011 May;241(1):260-8
pubmed: 21488902
Mol Med Rep. 2021 Jan;23(1):
pubmed: 33200798
FASEB J. 2019 Dec;33(12):13951-13965
pubmed: 31645142
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034
pubmed: 20066092
Cell Death Dis. 2018 Feb 19;9(3):290
pubmed: 29459719
Eur J Immunol. 2020 Jul;50(7):944-948
pubmed: 32428262
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2486-2496
pubmed: 30964175
Clin Sci (Lond). 2018 Nov 2;132(21):2285-2298
pubmed: 30237316
Genomics Proteomics Bioinformatics. 2016 Feb;14(1):42-54
pubmed: 26883671
Int J Mol Med. 2017 Jun;39(6):1338-1346
pubmed: 28440493
J Immunol. 2015 Jan 1;194(1):21-7
pubmed: 25527793
J Neuroimmune Pharmacol. 2014 Dec;9(5):629-41
pubmed: 24989845
Front Microbiol. 2020 Nov 13;11:596440
pubmed: 33281794
Biosci Rep. 2020 Feb 28;40(2):
pubmed: 31909418
Cancers (Basel). 2016 Mar 15;8(3):
pubmed: 26999211
Am J Cancer Res. 2016 Jun 01;6(6):1167-76
pubmed: 27429839
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G34-G40
pubmed: 31545920
Mol Oncol. 2019 Jan;13(1):46-60
pubmed: 30430751
IUBMB Life. 2019 Jul;71(7):956-968
pubmed: 30883005
Int J Biol Macromol. 2020 Mar 15;147:1248-1254
pubmed: 31739067
FEBS Open Bio. 2018 Feb 21;8(4):544-555
pubmed: 29632808
Int Immunopharmacol. 2020 Nov;88:106891
pubmed: 32853927
Biomed Pharmacother. 2018 May;101:195-200
pubmed: 29494956
Neoplasma. 2019 Jun 29;66(6):939-945
pubmed: 31307201

Auteurs

Mohammad Taheri (M)

Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Dominik A Barth (DA)

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Julia Kargl (J)

Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Graz, Austria.

Omidvar Rezaei (O)

Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Soudeh Ghafouri-Fard (S)

Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Martin Pichler (M)

Research Unit of Non-Coding RNAs and Genome Editing in Cancer, Division of Clinical Oncology, Department of Internal Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH